Related Experiment Video
Updated: Jun 2, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
DNA methylation changes in cancer
Minoru Toyota1, Eiichiro Yamamoto
1Department of Biochemistry, Sapporo Medical University, Chuo-ku, Sapporo, Japan.
Abstract:
DNA methylation of CpG islands, together with deacetylation of histone and methylation of histone H3 lysines 9 and 27 (K9/K27), can lead to silencing of tumor-suppressor genes. The mechanisms underlying DNA methylation changes in cancer involve alteration of the activity of DNA methyltransferases (DNMTs), inflammation, and viral infection. DNA methylation affects genes involved in cell-cycle checkpoints, apoptosis, angiogenesis, invasion, immune responses, and cellular signaling. Subsets of cancers show DNA methylation of multiple genes, indicating that these tumors have the CpG island methylator phenotype (CIMP). Cancers with CIMP show distinct genetic changes, including microsatellite instability and mutations in the BRAF Ser/Thr kinase gene. Repetitive sequences such as short and long interspersed repeat elements are often hypomethylated in cancer, and are implicated in chromosomal instability. DNA methylation is a reversible phenomenon, and DNMT inhibitors can induce gene expression due to demethylation.
Insights
DNA methylation and histone modifications silence tumor-suppressor genes in cancer. These epigenetic changes, driven by DNA methyltransferases (DNMTs), affect various cancer pathways and can be reversed by DNMT inhibitors.
Area of Science:
- Epigenetics and Cancer Biology
Background:
- Epigenetic alterations, including DNA methylation and histone modifications (deacetylation, H3K9/K27 methylation), are crucial in the silencing of tumor-suppressor genes.
- These epigenetic changes are implicated in various cancer hallmarks such as cell-cycle control, apoptosis, angiogenesis, and immune evasion.
Purpose of the Study:
- To elucidate the mechanisms driving DNA methylation changes in cancer.
- To understand the role of DNA methylation in specific cancer subtypes, including those with the CpG island methylator phenotype (CIMP).
Main Methods:
- Analysis of DNA methylation patterns in cancer genomes.
- Investigation of the involvement of DNA methyltransferases (DNMTs), inflammation, and viral infections in aberrant DNA methylation.
- Examination of epigenetic modifications in cancers exhibiting the CpG island methylator phenotype (CIMP).
Main Results:
- Aberrant DNA methylation, influenced by DNMT activity, inflammation, and viral factors, silences critical tumor-suppressor genes.
- Cancers with the CpG island methylator phenotype (CIMP) display distinct genetic alterations, including microsatellite instability and BRAF mutations.
- Hypomethylation of repetitive elements contributes to chromosomal instability in cancer.
Conclusions:
- DNA methylation is a key epigenetic mechanism driving cancer development and progression by affecting multiple gene functions.
- The reversibility of DNA methylation offers therapeutic potential, as demonstrated by DNMT inhibitors' ability to restore gene expression.
More Related Videos
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic cells are...

